Alert

Recommended Alerts

Sign Up For Alerts

In a Rare Move, ITC Applies Public Interest Factors to Exempt Research-Related Microfluidic Devices from Exclusion Order

The U.S. International Trade Commission (“ITC”) has become a popular venue for patent infringement actions, as it provides for fast and powerful exclusionary remedies against infringers in the form of exclusion and cease-and-desist orders, through which the ITC can bar importation of infringing products into the United States. Importantly, the ITC does not apply the equitable “eBay factors” before issuing such relief—instead, it must consider the so-called “public interest factors”: the effect of the orders upon (1) the public health and welfare, (2) competitive conditions in the United States economy, (3) the production of like or directly competitive articles in the United States, and (4) United States consumers.

Read More

Woglom to address London pharmaceutical patent conference


Time to Read: 1 minutes Practices: Intellectual Property

Eric C. Woglom, a partner in the Fish & Neave IP Group of Ropes & Gray, will discuss recent legislative and judicial developments affecting the U.S. pharmaceutical industry, including the status of proposed patent law reform measures, at the fifth annual Pharmaceutical Patent Life Cycles Conference in London on January 19-20, 2006.

Presented by C5, the conference provides authoritative information on strategies and developments in the field of pharmaceutical patents to a large audience of in-house and patent counsel, attorneys, patent agents and directors and managers of IP from pharmaceutical companies worldwide.

Cookie Settings